Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMT, Janssen Biotech Enter Research and License Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

AMT, Janssen Biotech Enter Research and License Pact

Janssen licenses biopharma candidate employing TRANSINT technology

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Applied Molecular Transport (AMT) has entered into a research collaboration and license agreement granting Janssen Biotech an exclusive, worldwide license for an orally administered biopharma candidate engineered for the treatment of inflammatory bowel diseases. AMT’s technology, TRANSINT, enables the development of oral biopharmaceuticals and RNA therapeutics for local gastrointestinal targeting or systemic release.
 
AMT is eligible to receive upfront license fees, support for research activities conducted in collaboration with Janssen, and development, regulatory and commercialization milestones, plus royalties on sales.
 
“The gastrointestinal submucosa is a region rich in immune targets that modulate local and systemic diseases, including inflammation,” said Tahir Mahmood, Ph.D., founder and chief business officer at Applied Molecular Transport. “The role of molecular trafficking technologies as engines for the development of next-generation, orally administered biopharmaceuticals has been recognized as a significant area of opportunity in the pharmaceutical industry. We are excited to collaborate with Janssen to advance this important platform strategy and program.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics